Pricing Log in Create free account

Biogen Inc. (BIIB) vs MIRA Pharmaceuticals, Inc. (MIRA)

Biogen Inc. and MIRA Pharmaceuticals, Inc. are both Drug Manufacturers General companies. Biogen Inc. is the larger, with a market value of $36.1B against $22.7M — 1588.5× the size. MIRA Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Biogen Inc. trades at 105×. Biogen Inc. has the higher net margin (3.37% vs 0.00%) and the higher return on invested capital (1.94% vs −12,016.1%). Across the 14 metrics below, Biogen Inc. leads on 11 and MIRA Pharmaceuticals, Inc. on 3.

Valuation

Metric BIIB MIRA Drug Manufacturers General median
P/E 105.24 n/m 26.51
P/S 3.57 n/m 3.49
P/B 1.94 2.88 5.28
Price to free cash flow 21.67 n/m 21.67
EV/EBITDA 18.65 n/m 14.73
EV/Sales 4.15 n/m 4.15
Earnings yield 0.95% (254.29%) 2.41%
Free cash flow yield 4.61% (19.71%) 4.07%

Profitability

Metric BIIB MIRA Drug Manufacturers General median
Gross margin 73.96% — 73.01%
Operating margin 7.53% 0.00% 18.34%
Net margin 3.37% 0.00% 7.31%
Free cash flow margin 16.45% 0.00% 18.56%
Return on equity 1.87% (710.85%) 5.80%
Return on assets 1.13% (684.27%) 2.28%
Return on invested capital 1.94% (12,016.10%) 6.26%

Growth

Metric BIIB MIRA Drug Manufacturers General median
Revenue growth (TTM) 2.30% — 6.72%
EPS growth (last fiscal year) (21.38%) (164.71%) 21.81%
Revenue growth, 5-year CAGR (5.96%) — 4.75%
Net income growth, 5-year CAGR (20.22%) 0.00% 0.00%

Health

Metric BIIB MIRA Drug Manufacturers General median
Debt to equity 0.39 0.00 0.62
Current ratio 1.95 200.19 1.39
Net debt to EBITDA 0.84 1.05 1.15

Dividend

Metric BIIB MIRA Drug Manufacturers General median
Dividend yield — — 2.32%
Payout ratio — — 0.59

Size

Metric BIIB MIRA Drug Manufacturers General median
Market cap 36.06b 22.70m 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack